Tandem Diabetes 
Care is developing the 
t:slim, a credit card-sized insulin pump that’s pending FDA approval. The company sought to make its pump sleek and stylish, bearing a closer resemblance to an iPhone than a medical device.

Tandem Diabetes Care is developing the t:slim, a credit card-sized insulin pump that’s pending FDA approval. The company sought to make its pump sleek and stylish, bearing a closer resemblance to an iPhone than a medical device.

TANDEM DIABETES CARE INC.

President and CEO: Kim Blickenstaff.

Financial data: Would not disclose.

No. of local employees: 96.

Investors: Domain Associates LLC of La Jolla, Delphi Ventures of Menlo Park, Kearny Venture Partners of San Francisco, TPG Biotech of San Francisco, HLM Venture Partners of San Francisco, and others.

Headquarters: Sorrento Valley.

Year founded: 2006.

Company description: A medical device company that’s in late-stage development of a compact touch-screen insulin pump for diabetics.

Key factors for success: To guide the design of functionality of its product, the company gathered input from thousands of people with diabetes and interviewed doctors about how to improve insulin delivery.

Tandem Diabetes Care Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99